110 related articles for article (PubMed ID: 20353369)
1. Effect of pretransplant hemoglobin blood level on kidney transplant outcome.
Abou-Jaoude MM; Nawfal N; Najm R; Shaheen J; Almawi WY
Exp Clin Transplant; 2009 Dec; 7(4):214-7. PubMed ID: 20353369
[TBL] [Abstract][Full Text] [Related]
2. Increasing levels of hemoglobin improve renal transplantation outcomes.
Lofaro D; Greco R; Papalia T; Bonofiglio R
Transplant Proc; 2011 May; 43(4):1036-8. PubMed ID: 21620046
[TBL] [Abstract][Full Text] [Related]
3. Anemia at 1 year after kidney transplantation has a negative long-term impact on graft and patient outcomes.
Marcén R; Galeano C; Fernandez-Rodriguez A; Jiménez S; Teruel JL; Burgos FJ; Quereda C
Transplant Proc; 2012 Nov; 44(9):2593-5. PubMed ID: 23146465
[TBL] [Abstract][Full Text] [Related]
4. Effect of pre-transplantation hemoglobin concentration on prognosis of renal transplant recipients.
Na N; Hong LQ; Miao B; Hua XF; Huang ZY
Chin Med J (Engl); 2011 Apr; 124(8):1213-6. PubMed ID: 21542999
[TBL] [Abstract][Full Text] [Related]
5. Early renal transplantation after donor renal angiography affects initial graft function.
Tutal E; Canver B; Can S; Colak T; Sezer S; Haberal M
Transplant Proc; 2012 Jun; 44(5):1227-30. PubMed ID: 22663990
[TBL] [Abstract][Full Text] [Related]
6. Donor-recipient age difference and graft survival in living donor kidney transplantation.
Lee YJ; Chang JH; Choi HN; Jung JY; Kim YS; Chung WK; Park YH; Lee HH
Transplant Proc; 2012 Jan; 44(1):270-2. PubMed ID: 22310630
[TBL] [Abstract][Full Text] [Related]
7. Anemia in living donor kidney transplantation.
Sert I; Colak H; Tugmen C; Dogan SM; Karaca C
Transplant Proc; 2013; 45(6):2238-43. PubMed ID: 23714109
[TBL] [Abstract][Full Text] [Related]
8. Sex matching plays a role in outcome of kidney transplant.
Abou-Jaoude MM; Abou-Jaoude WJ; Almawi WY
Exp Clin Transplant; 2012 Oct; 10(5):466-70. PubMed ID: 23031085
[TBL] [Abstract][Full Text] [Related]
9. Proteinuria is a predictor of posttransplant anemia.
Bonofiglio R; Lofaro D; Greco R; Senatore M; Papalia T
Transplant Proc; 2011 May; 43(4):1063-6. PubMed ID: 21620053
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
[TBL] [Abstract][Full Text] [Related]
11. Effect of pretransplantation hemoglobin blood concentration on renal allograft survival and function.
Abou-Jaoude MM; Nawfal N; Najm R; Honeidi M; Shaheen J; Almawi WY
Transplant Proc; 2010 Apr; 42(3):760-2. PubMed ID: 20430165
[TBL] [Abstract][Full Text] [Related]
12. Relation between pretransplant serum levels of soluble CD30 and acute rejection during the first 6 months after a kidney transplant.
Shooshtarizadeh T; Mohammadali A; Ossareh S; Ataipour Y
Exp Clin Transplant; 2013 Jun; 11(3):229-33. PubMed ID: 23477385
[TBL] [Abstract][Full Text] [Related]
13. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
Wang D; Chen JH; Wu WZ; Yang SL; Wu GJ; Wang H; Tan JM
Transplant Proc; 2007; 39(1):69-72. PubMed ID: 17275476
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with thymoglobulin and antithymocyte globulin-Fresenius as induction therapy in renal transplant patients: a retrospective study.
Cicora F; Mos F; Paz M; Roberti J
Exp Clin Transplant; 2013 Oct; 11(5):418-22. PubMed ID: 23909577
[TBL] [Abstract][Full Text] [Related]
15. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of sHLA-G-mediated with better graft acceptance in early posttransplantation.
Jin HL; Li CR; Xiao L; Shi BY; Cai M; Li ZL; Wang S; Chen LP; Zhan SL; Li PC
Transplant Proc; 2012 Jun; 44(5):1259-61. PubMed ID: 22663996
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide exposure pretransplant is associated with complications in the first year after kidney transplant.
Sharif A; Chand S; Krishnan H; Smith S; Markarian N; Borrows R; Cockwell P
Exp Clin Transplant; 2011 Aug; 9(4):236-40. PubMed ID: 21819367
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of antibodies improves outcome of renal transplantation.
Trivedi HL; Vanikar AV; Gumber MR; Patel HV; Shah PR; Kute VB
Transplant Proc; 2012 Jan; 44(1):241-7. PubMed ID: 22310623
[TBL] [Abstract][Full Text] [Related]
19. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
[TBL] [Abstract][Full Text] [Related]
20. Treatment of anemia with erythropoietin-stimulating agents in kidney transplant recipients and chronic kidney disease-another drawback of immunosuppression?
Malyszko J; Glowinska I; Mysliwiec M
Transplant Proc; 2012 Dec; 44(10):3013-6. PubMed ID: 23195016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
